Manatuck Hill Partners’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-125,000
| Closed | -$966K | – | 81 |
|
|
2020
Q1 | $966K | Buy |
+125,000
| New | +$966K | 0.89% | 33 |
|
|
2019
Q1 | – | Sell |
-194,100
| Closed | -$1.57M | – | 97 |
|
|
2018
Q4 | $1.57M | Sell |
194,100
-109,200
| -36% | -$882K | 0.81% | 42 |
|
|
2018
Q3 | $3.91M | Buy |
303,300
+45,100
| +17% | +$582K | 1.47% | 25 |
|
|
2018
Q2 | $2.94M | Buy |
258,200
+12,000
| +5% | +$137K | 1.18% | 26 |
|
|
2018
Q1 | $1.74M | Buy |
246,200
+72,600
| +42% | +$512K | 0.92% | 30 |
|
|
2017
Q4 | $1.13M | Buy |
173,600
+23,600
| +16% | +$153K | 0.59% | 42 |
|
|
2017
Q3 | $930K | Buy |
+150,000
| New | +$930K | 0.45% | 46 |
|
|
2017
Q2 | – | Sell |
-155,000
| Closed | -$698K | – | 88 |
|
|
2017
Q1 | $698K | Buy |
155,000
+105,000
| +210% | +$473K | 0.3% | 60 |
|
|
2016
Q4 | $273K | Buy |
+50,000
| New | +$273K | 0.13% | 71 |
|